Insilico Lands $177M Drug Discovery Deal
Polymarket · x · 2026-07-13
China Medical System has agreed to pay Insilico Medicine up to $177 million to develop treatments for central nervous system diseases.
This AI drug discovery collaboration comes with a clear financial cap, demonstrating the continued commercialization of AI drug discovery in the pharmaceutical industry.
More from Venture
- 8 open-source projects you can turn into income: n8n, Supabase, Ghost and more — Shruti_0810 · 2026-09-11
- A 160k-word knowledge base landed a $280k GEO contract — but the service model barely scales — sujingshen · 2026-09-11
- Indie hackers aren't just engineers or marketers — AI lets one builder run the whole loop — alexmacgregor__ · 2026-09-11
- Supabase grew ARR from $1M to $170M in 5 years, now valued at $10.5B — FinanceYF5 · 2026-09-11
- Glean Is Worth $7.2B, but What's Actually Its Moat? — yogthinks · 2026-09-11
- VC advice for Indian founders: stop pitching that you'll be in SF, go where customers are — vaibhavbetter · 2026-09-11